Ultime notizie per ImmunityBio (NASDAQ:IBRX) Azioni

IMMUNITYBIO INC

ImmunityBio

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

ImmunityBio Inc

Truist Securities analyst Terry Tillman maintains OneStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OS#NASDAQ">OS</a>) with a Buy and lowers the price target from $37 to $27.

News

Price Target

Analyst Ratings

Truist Securities Maintains Buy on OneStream, Lowers Price Target to $27

Truist Securities analyst Terry Tillman maintains BlackLine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BL#NASDAQ">BL</a>) with a Hold and lowers the price target from $55 to $40.

Truist Securities Maintains Hold on BlackLine, Lowers Price Target to $40

Trading Ideas

JNVR

Janover Shares Resume Trade Then Again Halt On Circuit Breaker To The Upside, Stock Now Up 347%

Truist Securities analyst Youssef Squali initiates coverage on Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) with a Buy rating and announces Price Target of $150.

Initiation

RDDT

Truist Securities Initiates Coverage On Reddit with Buy Rating, Announces Price Target of $150

WIIM

EQNR

FANG

SHEL

Shares of energy stocks are trading lower as crude oil falls to 2021 levels, following OPEC+'s decision to accelerate production hikes. The market is also grappling with fears of a recession, fueled by President Trump's recent tariff announcements and China's retaliatory measures, which have heightened concerns over global demand.

HC Wainwright &amp; Co. analyst Kevin Dede initiates coverage on Fold Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLD#NASDAQ">FLD</a>) with a Buy rating and announces Price Target of $7.

HC Wainwright & Co. Initiates Coverage On Fold Holdings with Buy Rating, Announces Price Target of $7

BJDX

Bluejay Diagnostics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 101.7%

Oil is trading lower, falling to 2021 levels, after OPEC+'s decision to accelerate production hikes. The market is also grappling with fears of a recession, fueled by President Trump's recent tariff announcements and China's retaliatory measures, which have heightened concerns over global demand.

Truist Securities analyst Terry Tillman downgrades Udemy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UDMY#NASDAQ">UDMY</a>) from Buy to Hold and lowers the price target from $10 to $7.

Downgrades

UDMY

Truist Securities Downgrades Udemy to Hold, Lowers Price Target to $7

Barclays analyst Benjamin Budish maintains Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) with a Overweight and lowers the price target from $76 to $45.

HOOD

Barclays Maintains Overweight on Robinhood Markets, Lowers Price Target to $45

Piper Sandler analyst Charles Neivert maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Neutral and lowers the price target from $120 to $105.

Piper Sandler Maintains Neutral on Westlake, Lowers Price Target to $105

Piper Sandler analyst Charles Neivert maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Neutral and lowers the price target from $33 to $26.

Piper Sandler Maintains Neutral on Olin, Lowers Price Target to $26

VTRS

Viatris shares are trading lower after the company agreed to pay up to $335M to settle opioid-related claims.

ABNB

Adtalem Global Education Inc. Common Stock

ATGE

BBWI

BROS

BYON

CAVA

CHWY

CVNA

DKNG

DUOL

EXPE

JAKK

LAUR

LAZR

LCID

LINC

MBLY

MULN

NTCL

NWTN

PSNY

PTON

REAL

SERV

SHAK

TSLA

WING

YOSH

ZSPC

Shares of companies in the broader consumer discretionary sector are trading lower amid trade war escalations and President Trump's sweeping tariffs, which are leading to a decline in consumer confidence. Some economists also predict that households will experience higher costs of goods as a result of these policies.

Tesla shares are trading lower after Wedbush maintained an Outperform rating on the stock but cut its price target from $550 to $315

Piper Sandler analyst Charles Neivert maintains LyondellBasell Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) with a Neutral and lowers the price target from $84 to $67.

Piper Sandler Maintains Neutral on LyondellBasell Industries, Lowers Price Target to $67

Piper Sandler analyst Charles Neivert maintains Quaker Houghton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWR#NYSE">KWR</a>) with a Neutral and lowers the price target from $140 to $120.

Piper Sandler Maintains Neutral on Quaker Houghton, Lowers Price Target to $120

Elon Musk is taking aim at Capitol Hill. The billionaire CEO of Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and SpaceX says the Department of Government Efficiency he leads is now turning its focus to members of Congress who have built massive fortunes while drawing relatively modest public salaries.
&#8220;How&#8217;d they get $20 million if they&#8217;re earning $200,000 a year? Nobody can explain that,&#8221; Musk said during a recent <a href="https://www.youtube.com/watch?v=keVBP1YwyUo">town hall</a> in Wisconsin. &#8220;We&#8217;re going to try to figure it out, and certainly stop it from happening.&#8221;
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li><a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">With Shares Starting at Just $1.52, This Could be Your Chance to Invest in the Future of Healthcare.</a></li>
</ul>
<h2 class="wp-block-heading">Wealth Raises Eyebrows</h2>
The issue of lawmakers&#8217; wealth has been gaining attention across social media and business shows alike. On a recent &#8220;Fox &amp; Friends&#8221; <a href="https://www.youtube.com/watch?v=y2BZA6H7PVA">segment</a>, Chris Josephs, co-founder of the stock-tracking Autopilot app, explained how his platform monitors trades made by members of Congress.&nbsp;
While disclosures exist, Josephs pointed out the real blind spot: &#8220;There isn&#8217;t too much that you can really see on the actual stock trading side [for politicians]. However, there is not much that you can really see into the spouses and dependents.&#8221;
Josephs added, &#8220;If I were Elon and recommend where to look for the suspicious stuff going on here, I would go right to the spouses and especially the children as well.&#8221;
Trending: <a href="https://www.benzinga.com/money/vatom-adv">Invest in the Future of Digital Engagement. Own a Piece of the $100 Billion Metaverse Today for Just $500.</a>
One <a href="https://www.benzinga.com/markets/25/02/43533599/what-you-can-learn-from-nancy-pelosis-pre-inauguration-stock-trades">example</a> that keeps coming up is former House Speaker Nancy Pelosi (D-CA), whose husband, Paul Pelosi, is a venture capitalist with a long history of <a href="https://www.benzinga.com/government/24/08/40496667/pelosi-profits-from-palo-alto-networks-earnings-rally-heres-how-much-former-speaker-is-up-on-2024-tr">investing in high-growth tech stocks</a>.&nbsp;
<h2 class="wp-block-heading">Musk Doubles Down</h2>
Musk isn&#8217;t just talking about Pelosi. During the town hall, an audience member asked Musk whether DOGE had uncovered any signs of money being routed through the U.S. Agency for International Development to &#8220;any of the radical left Democrats.&#8221;
Musk responded: "They'll send the money overseas to one NGO, then they'll go through a bunch of them&#8230; and I'm highly confident that a bunch of that money then comes back to the United States and lands in the pockets of the people you just mentioned."
Musk has not provided any concrete evidence to support these claims, and none of the individuals named have been formally accused of wrongdoing. He didn&#8217;t say anything about Republican lawmakers.&nbsp;
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
While Musk has stopped short of directly accusing anyone of illegal behavior, he says the current system deserves scrutiny. His push for transparency echoes calls made by politicians from both parties, including the former President Joe Biden and Rep. Ro Khanna (D-CA), who have <a href="https://www.benzinga.com/24/12/42538504/biden-endorses-ban-of-congressional-stock-trading-nobody-in-the-congress-should-be-able-to-make-money-in-the-stock-market-while-in-office">supported banning stock trading</a> by members of Congress.
&#8220;Nobody in the Congress should be able to make money in the stock market while they&#8217;re in the Congress,&#8221; Biden said in a December <a href="https://www.youtube.com/watch?v=ew8mOxXd5fc">interview</a> with political advisor Faiz Shakir.
Still, reform has stalled. "It is shameful that over three years after the pandemic&#8230; there still hasn't been a vote," Khanna told Benzinga.
<h2 class="wp-block-heading">Lawmakers Beat the Market</h2>
According to a <a href="https://unusualwhales.com/congress-trading-report-2024">report</a> from Unusual Whales for 2024, members of Congress didn't just beat the S&amp;P 500 — they crushed it. Democrats averaged 31.1% returns, Republicans 26.1%, compared to the S&amp;P's 24.9%.
<a href="https://www.benzinga.com/politics/25/02/43663526/elon-musk-questions-congress-members-wealth-where-did-they-get-all-the-money">Pelosi saw a 70.9% return</a> last year, placing her in the top 10. Five lawmakers had gains exceeding 100%.
Read Next:
<ul>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.55 per share now</a>.</li>
<li><a href="https://www.benzinga.com/money/startengine-own">The $1.3 billion startup investment boom: How this company's explosive growth is opening doors for everyday investors with a new $500 minimum</a></li>
</ul>

How'd They Get $20 Million On A $200K Salary?' Asks Musk As He Reveals Congress's 'Strangely Wealthy' Members Are Next In DOGE's Crosshairs

ICCT

iCoreConnect Shares Resume Trade

Piper Sandler analyst Charles Neivert maintains Eastman Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) with a Neutral and lowers the price target from $105 to $99.

Piper Sandler Maintains Neutral on Eastman Chemical, Lowers Price Target to $99

Press Releases

FDA Authorizes ImmunityBio to Provide Recombinant BCG (rBCG) to Urologists to Address TICE® BCG Shortage

ImmunityBio Receives FDA RMAT Designation for ANKTIVA® and CAR-NK for the Reversal of Lymphopenia in Patients Receiving Standard-of-Care Chemotherapy/Radiotherapy and in Treatment of Multiply Relapsed Locally Advanced or Metastatic Pancreatic Cancer

Legal

IMMUNITYBIO ALERT: Bragar Eagel & Squire, P.C. is Investigating ImmunityBio, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

ImmunityBio Reports Sales Momentum & Unit Growth Since Permanent J-code Issuance (J9028) in January 2025 and Financial Results for Year End 2024

ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, LLP Investigates Claims on Behalf of Investors

Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and ImmunityBio: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors

ImmunityBio to Host Investor Day

ImmunityBio to Host Key Opinion Leader and Investor Meeting to Provide Updates on Clinical Programs and ANKTIVA Commercial Launch

Comments

ImmunityBio

Notizie

Ultime notizie per ImmunityBio (NASDAQ:IBRX) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO